These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Calpain inhibitor, SJA6017, reduces the rate of formation of selenite cataract in rats. Tamada Y, Fukiage C, Mizutani K, Yamaguchi M, Nakamura Y, Azuma M, Shearer TR. Curr Eye Res; 2001 Apr; 22(4):280-5. PubMed ID: 11462167 [Abstract] [Full Text] [Related]
3. Comparison of various calpain inhibitors in reduction of light scattering, protein precipitation and nuclear cataract in vitro. Mathur P, Gupta SK, Wegener AR, Breipohl W, Ahrend MH, Sharma YD, Gupta YK, Vajpayee RB. Curr Eye Res; 2000 Dec; 21(6):926-33. PubMed ID: 11262616 [Abstract] [Full Text] [Related]
4. Nuclear cataract and light scattering in cultured lenses from guinea pig and rabbit. Fukiage C, Azuma M, Nakamura Y, Tamada Y, Shearer TR. Curr Eye Res; 1998 Jun; 17(6):623-35. PubMed ID: 9663852 [Abstract] [Full Text] [Related]
5. Exploration of cornea permeable calpain inhibitors as anticataract agents. Nakamura M, Yamaguchi M, Sakai O, Inoue J. Bioorg Med Chem; 2003 Apr 03; 11(7):1371-9. PubMed ID: 12628663 [Abstract] [Full Text] [Related]
6. The in vitro retardation of porcine cataractogenesis by the calpain inhibitor, SJA6017. Biswas S, Harris F, Singh J, Phoenix DA. Mol Cell Biochem; 2004 Jun 03; 261(1-2):169-73. PubMed ID: 15362500 [Abstract] [Full Text] [Related]
7. Comparison of cell-permeable calpain inhibitors and E64 in reduction of cataract in cultured rat lenses. Lampi KJ, Kadoya K, Azuma M, David LL, Shearer TR. Toxicol Appl Pharmacol; 1992 Nov 03; 117(1):53-7. PubMed ID: 1440613 [Abstract] [Full Text] [Related]
8. Structure-activity relationship study and drug profile of N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal (SJA6017) as a potent calpain inhibitor. Inoue J, Nakamura M, Cui YS, Sakai Y, Sakai O, Hill JR, Wang KK, Yuen PW. J Med Chem; 2003 Feb 27; 46(5):868-71. PubMed ID: 12593666 [Abstract] [Full Text] [Related]
9. The novel calpain inhibitor SJA6017 improves functional outcome after delayed administration in a mouse model of diffuse brain injury. Kupina NC, Nath R, Bernath EE, Inoue J, Mitsuyoshi A, Yuen PW, Wang KK, Hall ED. J Neurotrauma; 2001 Nov 27; 18(11):1229-40. PubMed ID: 11721741 [Abstract] [Full Text] [Related]
10. Superior prevention of calcium ionophore cataract by E64d. Azuma M, David LL, Shearer TR. Biochim Biophys Acta; 1992 Dec 10; 1180(2):215-20. PubMed ID: 1463773 [Abstract] [Full Text] [Related]
11. Calpain may contribute to hereditary cataract formation in sheep. Robertson LJ, Morton JD, Yamaguchi M, Bickerstaffe R, Shearer TR, Azuma M. Invest Ophthalmol Vis Sci; 2005 Dec 10; 46(12):4634-40. PubMed ID: 16303960 [Abstract] [Full Text] [Related]
12. Crystallin degradation and insolubilization in regions of young rat lens with calcium ionophore cataract. Iwasaki N, David LL, Shearer TR. Invest Ophthalmol Vis Sci; 1995 Feb 10; 36(2):502-9. PubMed ID: 7843919 [Abstract] [Full Text] [Related]
13. Oxidation enhances calpain-induced turbidity in young rat lenses. Nakamura Y, Fukiage C, Azuma M, Shearer TR. Curr Eye Res; 1999 Jul 10; 19(1):33-40. PubMed ID: 10415455 [Abstract] [Full Text] [Related]
14. Therapeutic efficacy of SJA6017, a calpain inhibitor, in rat spinal cord injury. Akdemir O, Uçankale M, Karaoğlan A, Barut S, Sağmanligil A, Bilguvar K, Cirakoğlu B, Sahan E, Colak A. J Clin Neurosci; 2008 Oct 10; 15(10):1130-6. PubMed ID: 18656362 [Abstract] [Full Text] [Related]
15. Drevogenin D prevents selenite-induced oxidative stress and calpain activation in cultured rat lens. Biju PG, Rooban BN, Lija Y, Devi VG, Sahasranamam V, Abraham A. Mol Vis; 2007 Jul 12; 13():1121-9. PubMed ID: 17653057 [Abstract] [Full Text] [Related]
16. The involvement of calpains in opacification induced by Ca2+-overload in ovine lens culture. Lee HY, Morton JD, Sanderson J, Bickerstaffe R, Robertson LJ. Vet Ophthalmol; 2008 Jul 12; 11(6):347-55. PubMed ID: 19046274 [Abstract] [Full Text] [Related]
17. Calcium ionophore induced proteolysis and cataract: inhibition by cell permeable calpain antagonists. Sanderson J, Marcantonio JM, Duncan G. Biochem Biophys Res Commun; 1996 Jan 26; 218(3):893-901. PubMed ID: 8579611 [Abstract] [Full Text] [Related]
18. Cell-Permeable Calpain Inhibitor SJA6017 Provides Functional Protection to Spinal Motoneurons Exposed to MPP. Samantaray S, Knaryan VH, M Del Re A, Woodward JJ, Shields DC, Azuma M, Inoue J, Ray SK, Banik NL. Neurotox Res; 2020 Oct 26; 38(3):640-649. PubMed ID: 32761446 [Abstract] [Full Text] [Related]
19. Amelioration of cataracts and proteolysis in cultured lenses by cysteine protease inhibitor E64. Shearer TR, Azuma M, David LL, Murachi T. Invest Ophthalmol Vis Sci; 1991 Mar 26; 32(3):533-40. PubMed ID: 1848210 [Abstract] [Full Text] [Related]
20. Involvement of calpain isoforms in ischemia-reperfusion injury in rat retina. Sakamoto YR, Nakajima TR, Fukiage CR, Sakai OR, Yoshida YR, Azuma MR, Shearer TR. Curr Eye Res; 2000 Jul 26; 21(1):571-80. PubMed ID: 11035539 [Abstract] [Full Text] [Related] Page: [Next] [New Search]